Use of IL-18 inhibitors in hypersensitivity disorders
Details for Australian Patent Application No. 2002331376 (hide)
International Classifications
Event Publications
6 February 2003 Complete Application Filed
Priority application(s): 01118811.7 10.08.01 EP; 02100735.6 20.06.02 EP
19 June 2003 Application Open to Public Inspection
Published as AU-B-2002331376
14 June 2007 Application Accepted
Published as AU-B-2002331376
18 October 2007 Standard Patent Sealed
25 October 2007 Assignment Registered
Applied Research Systems ARS Holding N.V. The patent has been assigned to Laboratoires Serono SA
4 June 2009 Assignment Registered
Laboratoires Serono SA The patent has been assigned to Merck Serono SA
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002331375-SPACE-EFFICIENT, SIDE-CHANNEL ATTACK RESISTANT TABLE LOOKUPS
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser